Vir Biotechnology Appoints Aziz Sawaf as Chief Financial Officer
Vir Biotechnology appointed Aziz Sawaf as Executive Vice President and Chief Financial Officer, effective October 5, 2026, leading finance, IT and investor relations. Sawaf was CFO of Theravance Biopharma since 2023 and brings more than 20 years of biopharma finance experience, including prior roles at Gilead Sciences.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.